Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (179)	1/8/2003 2:07:02 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

STEM Is up 24% after it announced earlier today that it has been granted a U.S.Patent with broad claims covering the transplantation of neural stem cells into the CNS and the peripheral nervous system including the spinal cord. STEM has also recently been issued other patents for drug screening using human neural stem cell cultures and methods for producing neurospheres. The shares opened on a good up-gap which has not been fully closed as the shares keep trading above its Dec.4-Dec.11-Dec.20 triple-top at the 1.30 level. On a close above 1.50 STEM may get to test its August H at 2.09 or even its April H at 2.58.<g> siliconinvestor.com siliconinvestor.com siliconinvestor.com Bernard